4 results
The primary objective is to compare the overall survival (OS) of patients receiving ASA404 or placebo in combination with paclitaxel and carboplatin for first-line treatment of stage IIIb/IV NSCLC
Primary Objective:The primary objective of the study is to compare overall survival between the ASA404 plus docetaxel group and the placebo plus docetaxel group Key Secondary Objectives:To compare Progression-Free Survival (PFS) and the Overall…
To evaluate the effectiveness of blood pressure (BP) home monitoring on the occurrence of hypertension, efficacy of BP treatment, QOL, health-related symptoms, work ability and life-style behaviour in women 40-60 yrs, after a previous PE in…
To assess which treatment leads to the best patient outcome on the short term (1 year) and the long term (5 years)